InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,487.03
(
0.25%
)
US TECH 100
19,430.40
(
0.14%
)
Dow Jones
38,834.86
(
0.15%
)
Brent Oil
84.61
(
-0.11%
)
Bitcoin
65,429.01
(
0.71%
)
Post# of 252255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: mcbio post# 148197

Tuesday, 09/04/2012 11:09:56 PM

Tuesday, September 04, 2012 11:09:56 PM

Post# of 252255

Could we say that the fact that there's already an approved drug on the market with the same MoA bodes well for chances of success for this BLRX drug?



Not really - they are going after an oncology indication, which is quite different from a stem cell transplant indication. Also plerixafor is a small molecule drug and this is a peptide.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up